Difference between revisions of "Minutes - Medication WG 2021-05-11"

From Health Level 7 Belgium Wiki
(Created page with "===== '''Attendees''' ===== * Bruno Casneuf * Dieter Sauvillers * Elhassan Baazizi * Hanne Vuegen * Jean-Louis Maggetto * Jean-Michel Polfliet * Jens Penny * José Costa...")
 
 
(One intermediate revision by the same user not shown)
Line 37: Line 37:
 
::* the purpose is to achieve the MS
 
::* the purpose is to achieve the MS
 
::* are we going to translate kmehr to FHIR ? lots of risks
 
::* are we going to translate kmehr to FHIR ? lots of risks
−
::* starting from something completely new: we risk to lose data fromo the past
+
::* starting from something completely new: we risk to lose data from the past, we need compatibility
 
:: can the care plan be left out from this WG ?
 
:: can the care plan be left out from this WG ?
 
* We miss the definition of the MS  
 
* We miss the definition of the MS  
 +
::* currently the MS in kmehr is visualised in a document
 +
::* MS can be the scheme for Vitalink
 +
::* there is a type/version
 +
* What if an indication/treatment is confidential to one GP, one pharmacist will know of the dipsense of the medication without the indication, what about sharing to the vault
 +
::* will it be shared to the vault? mechanisms will have to be put in place
 +
::* permission resource will have to be added
 +
* medication treatment vs medication summary vs medication scheme: there is a lack of detail in the modelling
 +
::* medication summary : sort of a view/snapshot on the medication
 +
::* medication scheme: digested scheme of a patient's medications
 +
* kmehr MS with a concept of different medication treatments: what contains the list of medication treatment lines ? the medication treatment
  
−
 
+
* There is a need for examples and compilation to documents
−
----*
+
* Therefore it would be useful to start a list with the examples that we need
−
* Definitions related to Medication Scheme: http://build.fhir.org/ig/hl7-be/riziv-medication-record/toc.html
+
::* psychiatric medication with privacy settings
−
::* not updated on https://build.fhir.org/ig/hl7-be/hl7-be-fhir-medication/branches/master/medicationrecord-definitions.html yet
+
::* medication having same substance used for different indications and different posologies
−
::* treatment item is now treatment line
+
::* distinction between hospital treatment and home therapy
−
::* treatment is not about allergies, is what the doctor prescribes, can be updated by someone else (optional)
+
::* interactions between home therapy and psychiatric medication
−
::* treatment consists of treatment lines
+
::* magistral preparations
−
::* treatment lines: do we split this by indication ? TBC
+
::* need to see clear example of and difference b/w treatments and summary
−
::* treatment summary: will have lines but different lines, different from what one doctor intended
+
* Do we need support from pharmacist ?
−
::* patient can have different treatments, a treatment can be updated by different doctors
+
::* José will ask input from vidis
−
::* Medication summary can be constructed by a system or by a person
+
::* Pablo will have a look
−
::* Medication Record has all the data related to usage of medication of a person
+
::* Jens will try to provide input
−
::* who owns the treatment line ? the doctor but it can be updated by other doctors
+
::* Tom H will check
−
::* an indication might be linked to a treatment, it is not mandatory: none to multiple indications are possible
 
−
::* use of word treatment is not correct in its scientific way but is linked to the usage of a medication
 
−
::* How does het Medication Scheme fit here ? José is showing data model of medication record: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-data-model.html
 
−
::::* use case #1: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-scenario-1.html : a medication for 3 different indications ; what does the summary have to show ? is this 3 or 1 treatments ?
 
−
::* José is showing the FHIR resources: http://build.fhir.org/ig/hl7-be/riziv-medication-record/medicationrecord-fhir-resources.html
 
−
::::* Usage statement: here patient can indicate that he doesn't take the medication or that he only takes half of the dose
 
−
::* Remark: the current implementation of the medication scheme is less complex but causes already plenty of issues in the field
 
−
::* Question: do we need 1 central repository ? No, to be discussed in detail next meeting
 
  
 
'''Action items for next meeting'''
 
'''Action items for next meeting'''
 
::* each one of us to check offline and with his team to continue discussion on treatment lines
 
::* each one of us to check offline and with his team to continue discussion on treatment lines
 +
::* status of approval of medication history : to provide by HL7 Belgium
  
−
 
+
'''Next meeting May 25 at 11AM'''
−
'''Next meeting May 11 at 11AM'''
 

Latest revision as of 10:02, 11 May 2021

Attendees
  • Bruno Casneuf
  • Dieter Sauvillers
  • Elhassan Baazizi
  • Hanne Vuegen
  • Jean-Louis Maggetto
  • Jean-Michel Polfliet
  • Jens Penny
  • José Costa Teixeira
  • Karlien Erauw
  • Pablo Christiaens
  • Richard Francken
  • Robin Bosman
  • Tom De Backer
  • Tom Henkens
  • Will van Norel
Excused/Not present
  • Anne Nerenhausen
  • Annemieke Vergauwe
  • Jan Lenie
  • Jeroen De Wilde
  • Lars Vanreppelen
  • Marc Buckens
  • Nils Devos


Agenda
  • feedback on the model
Minutes
  • Magistral preparations: no update
  • What is the purpose and intent of the high level modelling towards the scope of the medication scheme project and exchange of the related MS information, including the outcome
  • the purpose of the logical model is having a common understanding what the data means apart from the FHIR modelling
  • logical model is perceived as a flow
  • What do we want to achieve here ? the MS, the careplan, ...
  • the purpose is to achieve the MS
  • are we going to translate kmehr to FHIR ? lots of risks
  • starting from something completely new: we risk to lose data from the past, we need compatibility
can the care plan be left out from this WG ?
  • We miss the definition of the MS
  • currently the MS in kmehr is visualised in a document
  • MS can be the scheme for Vitalink
  • there is a type/version
  • What if an indication/treatment is confidential to one GP, one pharmacist will know of the dipsense of the medication without the indication, what about sharing to the vault
  • will it be shared to the vault? mechanisms will have to be put in place
  • permission resource will have to be added
  • medication treatment vs medication summary vs medication scheme: there is a lack of detail in the modelling
  • medication summary : sort of a view/snapshot on the medication
  • medication scheme: digested scheme of a patient's medications
  • kmehr MS with a concept of different medication treatments: what contains the list of medication treatment lines ? the medication treatment
  • There is a need for examples and compilation to documents
  • Therefore it would be useful to start a list with the examples that we need
  • psychiatric medication with privacy settings
  • medication having same substance used for different indications and different posologies
  • distinction between hospital treatment and home therapy
  • interactions between home therapy and psychiatric medication
  • magistral preparations
  • need to see clear example of and difference b/w treatments and summary
  • Do we need support from pharmacist ?
  • José will ask input from vidis
  • Pablo will have a look
  • Jens will try to provide input
  • Tom H will check

Action items for next meeting

  • each one of us to check offline and with his team to continue discussion on treatment lines
  • status of approval of medication history : to provide by HL7 Belgium

Next meeting May 25 at 11AM

Retrieved from "https://wiki.hl7belgium.org/index.php?title=Minutes_-_Medication_WG_2021-05-11&oldid=1093"